172 related articles for article (PubMed ID: 21245273)
21.
Mileto SJ; Jardé T; Childress KO; Jensen JL; Rogers AP; Kerr G; Hutton ML; Sheedlo MJ; Bloch SC; Shupe JA; Horvay K; Flores T; Engel R; Wilkins S; McMurrick PJ; Lacy DB; Abud HE; Lyras D
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8064-8073. PubMed ID: 32198200
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile-derived membrane vesicles induce the expression of pro-inflammatory cytokine genes and cytotoxicity in colonic epithelial cells in vitro.
Nicholas A; Jeon H; Selasi GN; Na SH; Kwon HI; Kim YJ; Choi CW; Kim SI; Lee JC
Microb Pathog; 2017 Jun; 107():6-11. PubMed ID: 28284851
[TBL] [Abstract][Full Text] [Related]
23. Differential effects of varying concentrations of clostridium difficile toxin A on epithelial barrier function and expression of cytokines.
Johal SS; Solomon K; Dodson S; Borriello SP; Mahida YR
J Infect Dis; 2004 Jun; 189(11):2110-9. PubMed ID: 15143480
[TBL] [Abstract][Full Text] [Related]
24. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
25. Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.
McConnie R; Kastl A
Curr Gastroenterol Rep; 2017 Aug; 19(8):34. PubMed ID: 28707191
[TBL] [Abstract][Full Text] [Related]
26. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
Lamont JT
Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
[TBL] [Abstract][Full Text] [Related]
27. Bile salt inhibition of host cell damage by Clostridium difficile toxins.
Darkoh C; Brown EL; Kaplan HB; DuPont HL
PLoS One; 2013; 8(11):e79631. PubMed ID: 24244530
[TBL] [Abstract][Full Text] [Related]
28. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
29. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling.
Kim DH; Lee IH; Nam ST; Nam HJ; Kang JK; Seok H; Hwang JS; Kim H
J Microbiol Biotechnol; 2014 May; 24(5):696-703. PubMed ID: 24509250
[TBL] [Abstract][Full Text] [Related]
30. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
[TBL] [Abstract][Full Text] [Related]
31. Extra-Intestinal Effects of
Tonon F; Di Bella S; Grassi G; Luzzati R; Ascenzi P; di Masi A; Zennaro C
Cells; 2020 Dec; 9(12):. PubMed ID: 33271969
[No Abstract] [Full Text] [Related]
32. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.
Savidge TC; Pan WH; Newman P; O'brien M; Anton PM; Pothoulakis C
Gastroenterology; 2003 Aug; 125(2):413-20. PubMed ID: 12891543
[TBL] [Abstract][Full Text] [Related]
33. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
34. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
Kelly CP; Pothoulakis C; Orellana J; LaMont JT
Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
[TBL] [Abstract][Full Text] [Related]
35. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
[TBL] [Abstract][Full Text] [Related]
36. Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts.
Schleupner MA; Garner DC; Sosnowski KM; Schleupner CJ; Barrett LJ; Silva E; Hirsch D; Guerrant RL
J Clin Microbiol; 1995 Jul; 33(7):1755-9. PubMed ID: 7665642
[TBL] [Abstract][Full Text] [Related]
37. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile toxin: cytoskeletal changes and lactate dehydrogenase release in hepatocytes.
Grossmann EM; Longo WE; Kaminski DL; Smith GS; Murphy CE; Durham RL; Shapiro MJ; Norman JG; Mazuski JE
J Surg Res; 2000 Feb; 88(2):165-72. PubMed ID: 10644484
[TBL] [Abstract][Full Text] [Related]
39. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.
Linevsky JK; Pothoulakis C; Keates S; Warny M; Keates AC; Lamont JT; Kelly CP
Am J Physiol; 1997 Dec; 273(6):G1333-40. PubMed ID: 9435559
[TBL] [Abstract][Full Text] [Related]
40. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
